Open AccessA BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
Author(s) -
Paul Keown,
P Häyry,
Peter J. Morris,
C Stiller,
C. F. Barker,
Lisa Carr,
David Landsberg,
Ian R. Hardie,
Russell J. Rigby,
Helena Isoniemi,
Derek W. R. Gray,
Philip Belitsky,
A. Nicholson McDonald,
Mathew Th,
A. R. Clarkson,
Lindsay J. Barratt,
B. Buchholz,
Rowan G. Walker,
G Kirste,
Norman Muirhead,
David J. Tiller,
Geoffrey G. Duggin,
Philip F. Halloran,
Pierre Daloze,
Gilles St. Louis,
David Russell,
D Ludwin,
P Vialtel,
U Binswanger,
Buckels Ja,
Jean Louis Touraine,
David P. Hickey,
Giuseppe Remuzzi,
Giuseppe Locatelli,
F.T. Lam,
Ed Tapper
Publication year - 1996
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199604150-00008
Subject(s) - medicine , azathioprine , mycophenolic acid , transplantation , discontinuation , mycophenolate , gastroenterology , regimen , imp dehydrogenase , surgery , clinical trial , clinical endpoint , kidney transplantation , urology , disease